Compugen (CGEN) Revenue Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 64.24% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.82% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 19.04% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3,790.58% |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | -4.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.73% |
| Dec 31, 2025 | 4,477.29% |
| Sep 30, 2025 | -88.96% |
| Jun 30, 2025 | -81.24% |
| Mar 31, 2025 | -10.75% |
| Dec 31, 2024 | -95.60% |
| Dec 31, 2023 | 346.12% |
| Dec 31, 2016 | -99.36% |
| Sep 30, 2016 | -69.43% |
| Jun 30, 2016 | 122.42% |
| Mar 31, 2016 | -81.87% |
| Dec 31, 2015 | 26.88% |
| Sep 30, 2015 | -86.67% |
| Jun 30, 2015 | -88.65% |
| Mar 31, 2015 | -75.95% |
| Dec 31, 2014 | 269.13% |
| Sep 30, 2014 | 8.05% |
| Jun 30, 2014 | 8,827.27% |
| Mar 31, 2014 | 1,216.67% |
| Dec 31, 2013 | 1,224.63% |
| Sep 30, 2013 | 1,372.22% |
| Dec 31, 2010 | 660.00% |